Marc Forth
CIK 1816988 · CHIEF EXECTUIVE OFFICER · last filed 2025-05-23
Marc Forth is a CHIEF EXECTUIVE OFFICER who has filed 4 SEC Form 4 insider transactions across 3 companies since 2023. The most recent filing, for AEON, was dated May 23, 2025. Current disclosed insider exposure totals $536.7K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$536.7K
3
4
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AEON | CHIEF EXECTUIVE OFFICER | 750,547 | $0.72 | $536.7K | $0 | 2 | 2025-05-23 |
| AEON Biopharma, Inc. (AEON.WS) Delisted | CHIEF EXECTUIVE OFFICER | — | $1.05 | — | $0 | 1 | 2024-03-21 |
| AEON Biopharma, Inc. (PMGMW) Delisted | Chief Executive Officer | — | $0.02 | — | $0 | 1 | 2023-07-24 |
Recent Filings
4 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-05-23 | AEON | Grant (A) | — | $0 | EDGAR |
| 2024-09-04 | AEON | Grant (A) | +470,692 | $0 | EDGAR |
| 2024-03-21 | AEON Biopharma, Inc. (AEON.WS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-07-24 | AEON Biopharma, Inc. (PMGMW) Delisted | Grant (A) | — | $0 | EDGAR |